about
The transcription factor p53: not a repressor, solely an activatorMdmX is a substrate for the deubiquitinating enzyme USP2aSpi-1/PU.1 is a positive regulator of the Fli-1 gene involved in inhibition of erythroid differentiation in friend erythroleukemic cell linesMutational hotspots in the TP53 gene and, possibly, other tumor suppressors evolve by positive selection.MicroRNA in carcinogenesis & cancer diagnostics: a new paradigmThe more the messier: centrosome amplification as a novel biomarker for personalized treatment of colorectal cancersRepression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene productTumor-suppressor genes: cardinal factors in inherited predisposition to human cancersRapid screening of protein profiles of human breast cancer cell lines using non-porous reversed-phase high performance liquid chromatography separation with matrix-assisted laser desorption/ionization time-of-flight mass spectral analysis.Signs of positive selection of somatic mutations in human cancers detected by EST sequence analysisInter-relationship between microsatellite instability, thymidylate synthase expression, and p53 status in colorectal cancer: implications for chemoresistanceCharacteristics of primary and immortalized fibroblast cells derived from the miniature and domestic pigs.The Q300 gene: a novel transcription unit induced in simian virus 40-infected and -transformed mouse cellsDemystified ... p53.Expression and clinicopathologic significance of TUFM and p53 for the normal-adenoma-carcinoma sequence in colorectal epitheliaMelatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis.In vivo recombinant adenovirus-mediated p53 gene therapy in a syngeneic rat model for colorectal cancer.Molecular epidemiology of human cancer risk: gene-environment interactions and p53 mutation spectrum in human lung cancer.Mechanisms of p53 loss in human sarcomas.p53 mutations in colorectal cancerAccumulation of p53 protein in inverted transitional cell papilloma of the urinary bladder.Wild-type, but not mutant, human p53 proteins inhibit the replication activities of simian virus 40 large tumor antigen.Frequent mutation of the p53 gene in human esophageal cancerThe transforming and suppressor functions of p53 alleles: effects of mutations that disrupt phosphorylation, oligomerization and nuclear translocation.The history of p53. A perfect example of the drawbacks of scientific paradigms.The p53 tumour suppressor protein.The current status of tailor-made medicine with molecular biomarkers for patients with clear cell renal cell carcinoma.Genetic alterations in colorectal cancer.Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 statusLoss of p53 and centrosome hyperamplification.Fuse binding protein antagonizes the transcription activity of tumor suppressor protein p53.Nickel-induced alterations in human renal epithelial cellsCytogenetic significance of chromosome 17 aberrations and P53 gene mutations as prognostic markers in oral squamous cell carcinomaPolyomavirus-mediated transformation: a model of multistep carcinogenesis.The polymerase chain reaction: its use in the molecular characterization and diagnosis of cancers.Nuclear protein phosphorylation and growth control.Evaluation of public cancer datasets and signatures identifies TP53 mutant signatures with robust prognostic and predictive valueCarcinogenic and systemic health effects associated with arsenic exposure--a critical review.Oncogenes and tumor suppressor genes: new biochemical tests.Lowly expressed ribosomal protein s19 in the feces of patients with colorectal cancer.
P2860
Q24273295-939CE20B-2389-48E5-9B4D-C931320401BBQ24336863-DC008FD6-D661-46CC-90F2-7180575A8D92Q24554758-2C621A39-A2E2-4302-9046-E734FCA85055Q25257243-2251AC03-3ED3-47C2-9417-54859258B7A7Q26863669-F4FCB839-5717-487F-9175-0C539B5ADC87Q28072910-0AD649A4-4101-49BF-BE1A-5822771AAE3EQ28645822-87781AEF-945A-4AAB-AE89-648C04BE936CQ30499489-CAD28357-7496-4BA5-AFEE-00599AF857F1Q30770017-B5B35D7B-8BD1-4189-887D-5FF21F8A1F69Q33233542-52065ACA-7FF4-46E8-8E83-9F40A039041EQ33245747-E7B07988-0E93-4ED9-A7D4-44BA7A74F894Q33286432-4600B0B9-62F7-43A6-95FE-44CE7DAA884AQ33339665-508E5756-A16A-4D74-990E-A9C92A5E7BDFQ33588367-CFE6B396-26EA-47C9-AABD-B0935BCF9A61Q33613015-EE1297C9-3643-4D2B-ACC2-E2216AF0193AQ33624824-64A1195C-4A41-4E22-BFE7-DC43B7700243Q33629594-C676B0E3-103D-4B00-9A8A-BE3988CBE77CQ33643298-750B6A37-5257-4490-884C-92E215324B72Q33722859-E4CCFFB7-662A-401C-9308-DC401294D03AQ33818791-168EA9C0-E8F8-416F-812E-5A466EEEE480Q33840053-69278805-34F9-4F16-ADDD-6DD9030B7009Q33913536-1ABE4EEC-05D6-4951-80DC-858DDBC82EA6Q33927516-E65DA2CC-6C0C-4AFB-B5DB-C1BEE0332C7BQ34045809-A5F943D2-02A6-46B5-A3CA-935DA1468450Q34142403-A896BD5F-D277-4930-AC2A-9256ADC97FCEQ34187832-94442E78-F373-4C72-AEF2-89AFF23C12EFQ34365135-72C749E0-BF94-4F8C-A4DD-9B9D56386445Q34638183-E153A586-57FF-4A58-829D-B70F89F6859DQ34705321-BD622CF5-11B3-498E-AB79-27F180F2FE1EQ34818333-ED179A25-EA46-426E-B0C7-D22041655E04Q34968621-43C9B5E7-6B18-4E3A-BF7D-08195573AA5AQ35032395-0A439DA5-9FD2-433F-8671-D46B4433D19BQ35122127-4CF506CC-D40E-4C75-9C0A-845F904A0929Q35225088-FBC1D2D6-9D08-4D0F-9F4A-040B20C1254BQ35367235-0CE0A3A3-1E2E-499B-AABD-6793D7A8D0A7Q35450130-D5CD7D9B-3B64-4B27-A7C9-C6ADE14D463CQ35503492-9DE85FB0-9073-44ED-A4E9-04D9944C059DQ35571581-DB3B0F4A-6C7E-4C81-B492-ACA96D533B6AQ35662775-0452A1DA-FB46-4342-8DB9-68DB5961A6C9Q35681386-D4F6D4CA-6BB3-44A3-8657-981932186551
P2860
description
1990 nî lūn-bûn
@nan
1990 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
p53: oncogene or anti-oncogene?
@ast
p53: oncogene or anti-oncogene?
@en
p53: oncogene or anti-oncogene?
@nl
type
label
p53: oncogene or anti-oncogene?
@ast
p53: oncogene or anti-oncogene?
@en
p53: oncogene or anti-oncogene?
@nl
prefLabel
p53: oncogene or anti-oncogene?
@ast
p53: oncogene or anti-oncogene?
@en
p53: oncogene or anti-oncogene?
@nl
P356
P1433
P1476
p53: oncogene or anti-oncogene?
@en
P2093
S Benchimol
P356
10.1101/GAD.4.1.1
P50
P577
1990-01-01T00:00:00Z